8min chapter

ACR on Air cover image

Immune Related Adverse Events of Checkpoint Inhibitors

ACR on Air

CHAPTER

Managing Immune-Related Adverse Events of Checkpoint Inhibitors

The chapter delves into the complexities of treating immune-related adverse events (IRA-Es) caused by combination therapies like CTLA4 and PD-1 or PDL1 inhibitors, emphasizing the need for a multidisciplinary approach involving oncologists and rheumatologists. It discusses the model adopted at Hopkins for handling IRAEs, highlighting a dedicated team of specialists collaborating with oncologists. The setup in the clinic to manage these adverse events is detailed, focusing on specialized equipment and refining systems for improved patient care.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode